Bryson Ethan O, Lipson Scott, Gevirtz Clifford
Department of Anesthesia, Mount Sinai Medical Center, 1 Gustave Levy Plaza, New York, NY 10029, USA.
Anesthesiol Clin. 2010 Dec;28(4):611-7. doi: 10.1016/j.anclin.2010.08.005.
Opioid abuse is a devastating, costly, and growing problem in the United States, and one for which treatment can be complicated by barriers such as access to care and legal issues. Only 12% to 15% of the opioid-dependent population is enrolled in methadone maintenance programs. A significant breakthrough occurred with passage of the Drug Addiction Treatment Act of 2000 (DATA 2000). For the first time in approximately 80 years, physicians could legally prescribe opioid medications for the treatment of opioid addiction. The opiate, so designated, was buprenorphine (Subutex).
在美国，阿片类药物滥用是一个具有毁灭性、代价高昂且不断加剧的问题，而治疗该问题可能会因诸如获得护理和法律问题等障碍而变得复杂。只有12%至15%的阿片类药物依赖人群参加了美沙酮维持治疗项目。2000年《药物成瘾治疗法》（DATA 2000）的通过带来了重大突破。大约80年来，医生首次能够合法开处阿片类药物用于治疗阿片类药物成瘾。这种被指定的阿片类药物是丁丙诺啡（舒倍生）。
